v3.22.2.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
NET REVENUE $ 237 $ 1,068 $ 1,887 $ 2,341
OPERATING EXPENSES        
Transaction expense 57,538 38,389 180,051 114,448
Sales and marketing 175,606 178,404 1,393,252 802,017
Product development 458,942 631,977 1,557,850 2,279,893
General and administrative 4,269,020 208,497 6,544,063 5,299,285
Total operating expenses 4,961,106 1,057,267 9,675,216 8,495,643
NET OPERATING LOSS (4,960,869) (1,056,199) (9,673,329) (8,493,302)
OTHER INCOME (EXPENSE)        
Interest income 164 51 1,043 310
Forgiveness of debt 92,660   92,660 95,425
Interest expense (254,314) (252,621) (760,915) (828,568)
Total other income (expense) (161,490) (252,570) (667,212) (732,833)
NET LOSS (5,122,359) (1,308,769) (10,340,541) (9,226,135)
LESS: Accrued preferred dividends (350,996) 72,219 (958,459) (462,008)
Net loss attributable to noncontrolling interests 101 101
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (5,473,355) $ (1,236,550) $ (11,298,899) $ (9,688,042)
BASIC AND DILUTED NET LOSS PER COMMON SHARE (in Dollars per share) $ (0.04) $ (0.01) $ (0.09) $ (0.08)
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING (in Shares) 123,627,213 123,366,102 123,567,903 122,574,431